Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Alzheimer's Dementia Prevention
NCT04098666Phase 3Active, not recruiting
- Sponsor
- Columbia University
- Start
- Mar 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in Mild Cognitive Impairment (MCI), sponsored by Columbia University. Started Mar 2021; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT04098666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098666.